Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$517M |
| 2 |
NXP Semiconductors
NXPI
|
+$351M |
| 3 |
Oracle
ORCL
|
+$279M |
| 4 |
Palo Alto Networks
PANW
|
+$268M |
| 5 |
Boston Scientific
BSX
|
+$204M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CERN
Cerner Corp
CERN
|
+$517M |
| 2 |
ExxonMobil
XOM
|
+$385M |
| 3 |
Cenovus Energy
CVE
|
+$292M |
| 4 |
PLAN
Anaplan, Inc.
PLAN
|
+$236M |
| 5 |
Phillips 66
PSX
|
+$222M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.76% |
| 2 | Financials | 7.66% |
| 3 | Healthcare | 7.12% |
| 4 | Industrials | 5.11% |
| 5 | Consumer Discretionary | 4.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Colgate-Palmolive
CL
$72.6B
| $165M | 0.1% |
2,053,334
-507,137
| -20% | -$39.7M |
|
127
PUT
AbbVie
ABBV
$468B
| $164M | 0.1% |
1,073,800
-1,023,900
| -49% | -$156M |
|
128
Bank of America
BAC
$431B
| $164M | 0.1% |
5,274,261
+1,304,054
| +33% | +$47M |
|
129
PUT
Eli Lilly
LLY
$1.12T
| $162M | 0.1% |
499,100
+23,700
| +5% | +$7.11M |
|
130
Aon
AON
$75.3B
| $162M | 0.1% |
599,769
+548,672
| +1,074% | +$158M |
|
131
Marvell Technology
MRVL
$213B
| $160M | 0.1% |
3,679,695
+2,221,193
| +152% | +$126M |
|
132
Ametek
AME
$54.9B
| $160M | 0.1% |
1,455,769
+624,368
| +75% | +$75.9M |
|
133
PUT
Qualcomm
QCOM
$169B
| $159M | 0.1% |
1,247,500
-489,800
| -28% | -$66.5M |
|
134
Tenet Healthcare
THC
$22.6B
| $159M | 0.1% |
3,021,415
+1,711,339
| +131% | +$119M |
|
135
Altria Group
MO
$110B
| $159M | 0.1% |
3,800,066
+1,931,183
| +103% | +$100M |
|
136
Blackrock
BLK
$179B
| $157M | 0.1% |
258,261
+23,164
| +10% | +$15.1M |
|
137
Trane Technologies
TT
$99.8B
| $155M | 0.1% |
1,195,924
+300,147
| +34% | +$41.5M |
|
|
AJRD
138
DELISTED
Aerojet Rocketdyne Holdings
AJRD
| $155M | 0.1% |
3,821,322
-765,687
| -17% | -$31M |
|
139
Microchip Technology
MCHP
$41.3B
| $155M | 0.1% |
2,664,421
+2,149,115
| +417% | +$142M |
|
140
CALL
State Street SPDR S&P Biotech ETF
XBI
$11.2B
| $154M | 0.1% |
2,079,300
+814,000
| +64% | +$61.1M |
|
141
NiSource
NI
$19.5B
| $154M | 0.1% |
5,221,376
-172,073
| -3% | -$5.21M |
|
142
PUT
Cigna
CI
$73.3B
| $154M | 0.1% |
583,400
+95,300
| +20% | +$24.6M |
|
143
Boeing
BA
$169B
| $153M | 0.1% |
1,122,218
+562,936
| +101% | +$83M |
|
144
PUT
Netflix
NFLX
$331B
| $153M | 0.09% |
8,734,000
-4,518,000
| -34% | -$100M |
|
145
IQVIA
IQV
$42.8B
| $152M | 0.09% |
700,691
+683,845
| +4,059% | +$149M |
|
146
Ovintiv
OVV
$18.5B
| $152M | 0.09% |
3,429,286
+3,191,232
| +1,341% | +$164M |
|
147
Public Service Enterprise Group
PEG
$36.2B
| $151M | 0.09% |
2,391,899
+233,953
| +11% | +$15.9M |
|
148
Constellation Brands
STZ
$23.2B
| $150M | 0.09% |
644,354
+421,061
| +189% | +$102M |
|
149
Skyworks Solutions
SWKS
$10.1B
| $149M | 0.09% |
1,607,837
+1,091,994
| +212% | +$118M |
|
150
Workday
WDAY
$49.4B
| $149M | 0.09% |
1,064,265
+487,575
| +85% | +$88.6M |
|
Similar funds
Israel Englander's Q2 2022 Portfolio in Review
As of Q2 2022, Israel Englander held 7,971 positions worth $161B, down 15% from $189B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Israel Englander deployed $7.94B of net new capital in Q2 2022, opening 1,144 new positions and adding to 2,588 existing holdings. Its largest new stake was M&T Bank: 828,809 shares worth $132M.
By sector, the portfolio is most concentrated in Technology at 7.8% of assets, up from 7.2% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was ExxonMobil, an estimated $385M trimmed.
- Israel Englander's largest Q2 2022 buy was M&T Bank: 828,809 shares worth $132M.
- Israel Englander added most to Invesco QQQ Trust in Q2 2022, an estimated $517M increase.
- Israel Englander's biggest Q2 2022 reduction was ExxonMobil, cutting an estimated $385M.
- Israel Englander fully exited Cerner Corp in Q2 2022, selling an estimated $517M.
- Israel Englander's ten largest holdings make up 23% of its $161B portfolio in Q2 2022.
- Israel Englander opened 1,144 new positions and closed 1,065 in Q2 2022.
- Israel Englander's portfolio value fell 15% quarter-over-quarter to $161B.
Based on Millennium Management's 13F filing for Q2 2022, filed 15 Aug 2022.